VBI Vaccines
VBIV
#10650
Rank
NZ$3.28 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.15%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$17.76. In 2022 the company made an earnings per share (EPS) of NZ-$23.12 a decrease over its 2021 EPS that were of NZ-$14.19.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$23.1262.96%
2021NZ-$14.1928.57%
2020NZ-$11.04-54.35%
2019NZ-$24.17-52.58%
2018NZ-$50.9810.23%
2017NZ-$46.2514.29%
2016NZ-$40.47-62.8%
2015NZ-$108.7990.68%
2014NZ-$57.05-7.95%
2013NZ-$61.98-57.97%
2012NZ-$147.49-78%
2011NZ-$670.503151.47%
2010NZ-$20.6223.87%
2009NZ-$16.65-18.48%
2008NZ-$20.4212.08%
2007NZ-$18.22-49.47%
2006NZ-$36.06
2005N/A-100%
2004NZ-$16.0311.94%
2003NZ-$14.32-81.89%
2002NZ-$79.08196.44%
2001NZ-$26.6884.33%
2000NZ-$14.47-65.37%
1999NZ-$41.79-29.45%
1998NZ-$59.2429.61%
1997NZ-$45.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.66-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.43-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.59-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA